Richard A Meier - Net Worth and Insider Trading

Richard A Meier Net Worth

The estimated net worth of Richard A Meier is at least $18 Million dollars as of 2024-04-18. Richard A Meier is the Director of Biomarin Pharmaceutical Inc and owns about 104,014 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $9 Million. Richard A Meier is the Exec. Vice Pres. and CFO of Teleflex Inc and owns about 20,147 shares of Teleflex Inc (TFX) stock worth over $4 Million. Richard A Meier is also the EVP & CFO of Intersect ENT Inc and owns about 124,471 shares of Intersect ENT Inc (XENT) stock worth over $4 Million. Besides these, Richard A Meier also holds Staar Surgical Co (STAA) . Details can be seen in Richard A Meier's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard A Meier has not made any transactions after 2022-05-02 and currently still holds the listed stock(s).

Transaction Summary of Richard A Meier

To

Richard A Meier Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard A Meier owns 6 companies in total, including Biomarin Pharmaceutical Inc () , Intersect ENT Inc () , and Owens & Minor Inc () among others .

Click here to see the complete history of Richard A Meier’s form 4 insider trades.

Insider Ownership Summary of Richard A Meier

Ticker Comapny Transaction Date Type of Owner
Biomarin Pharmaceutical Inc 2022-05-02 director
Intersect ENT Inc 2020-03-17 EVP & Chief Financial Officer
Owens & Minor Inc 2013-03-01 EVP & Chief Financial Officer
Staar Surgical Co 2016-05-20 director
Teleflex Inc 2010-03-19 Exec. Vice Pres. and CFO
Rockley Photonics Holdings Ltd 2022-10-20 President & CFO

Richard A Meier Latest Holdings Summary

Richard A Meier currently owns a total of 4 stocks. Among these stocks, Richard A Meier owns 104,014 shares of Biomarin Pharmaceutical Inc (BMRN) as of May 2, 2022, with a value of $9 Million and a weighting of 52.37%. Richard A Meier owns 20,147 shares of Teleflex Inc (TFX) as of March 19, 2010, with a value of $4 Million and a weighting of 23.35%. Richard A Meier also owns 124,471 shares of Intersect ENT Inc (XENT) as of March 17, 2020, with a value of $4 Million and a weighting of 19.56%. The other 1 stocks Staar Surgical Co (STAA) have a combined weighting of 4.72% among all his current holdings.

Latest Holdings of Richard A Meier

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BMRN Biomarin Pharmaceutical Inc 2022-05-02 104,014 90.47 9,410,147
TFX Teleflex Inc 2010-03-19 20,147 208.30 4,196,620
XENT Intersect ENT Inc 2020-03-17 124,471 28.24 3,515,061
STAA Staar Surgical Co 2016-05-20 18,300 46.30 847,290

Holding Weightings of Richard A Meier


Richard A Meier Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard A Meier has made a total of 2 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 3,878 shares on May 2, 2022, which brought Richard A Meier around $318,345.

According to the SEC Form 4 filings, Richard A Meier has made a total of 0 transactions in Teleflex Inc (TFX) over the past 5 years. The most-recent trade in Teleflex Inc is the acquisition of 5,000 shares on March 19, 2010, which cost Richard A Meier around $315,500.

According to the SEC Form 4 filings, Richard A Meier has made a total of 2 transactions in Intersect ENT Inc (XENT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Intersect ENT Inc is the acquisition of 5,000 shares on March 17, 2020, which cost Richard A Meier around $39,000.

More details on Richard A Meier's insider transactions can be found in the Insider Trading History of Richard A Meier table.

Insider Trading History of Richard A Meier

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard A Meier Trading Performance

GuruFocus tracks the stock performance after each of Richard A Meier's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard A Meier is 23.65%. GuruFocus also compares Richard A Meier's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard A Meier within 3 months outperforms 6 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Richard A Meier's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Richard A Meier

Average Relative Return

77.74%

Average relative return per transaction

Outperforming Transactions

89%

8 out of 9 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 14.34 23.65 46.92 77.74 51.13 32.35
Relative Return to S&P 500(%) 5.94 8.3 26.84 45.54 30.63 17.87

Richard A Meier Ownership Network

Ownership Network List of Richard A Meier

No Data

Ownership Network Relation of Richard A Meier


Richard A Meier Owned Company Details

What does Biomarin Pharmaceutical Inc do?

Who are the key executives at Biomarin Pharmaceutical Inc?

Richard A Meier is the director of Biomarin Pharmaceutical Inc. Other key executives at Biomarin Pharmaceutical Inc include director & Chief Executive Officer Jean Jacques Bienaime , GVP & Chief Accounting Officer Erin Burkhart , and VP & General Counsel George Eric Davis .

Biomarin Pharmaceutical Inc () Insider Trades Summary

Over the past 18 months, Richard A Meier made no insider transaction in Biomarin Pharmaceutical Inc (). Other recent insider transactions involving Biomarin Pharmaceutical Inc () include a net sale of 291,000 shares made by Jean Jacques Bienaime , a net sale of 61,000 shares made by Jeffrey Robert Ajer , and a net sale of 17,380 shares made by Brian Mueller .

In summary, during the past 3 months, insiders sold 139,229 shares of Biomarin Pharmaceutical Inc () in total and bought 0 shares, with a net sale of 139,229 shares. During the past 18 months, 482,233 shares of Biomarin Pharmaceutical Inc () were sold and 3,625 shares were bought by its insiders, resulting in a net sale of 478,608 shares.

Biomarin Pharmaceutical Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biomarin Pharmaceutical Inc Insider Transactions

No Available Data

Richard A Meier Mailing Address

Above is the net worth, insider trading, and ownership report for Richard A Meier. You might contact Richard A Meier via mailing address: C/o Intersect Ent, Inc., 1555 Adams Drive, Menlo Park Ca 94025.

Discussions on Richard A Meier

No discussions yet.